AqueSys

Date Founded
2006

Innovation
AqueSys is developing a proprietary surgical device for the treatment of glaucoma. Glaucoma is the second leading cause of blindness worldwide and affects up to 65 million individuals.

Funding
AqueSys has raised $6.9 million in Series A financing and is currently closing on a Series B financing totaling $9.0 million.

Contact
2750 Premiere Parkway, Suite 200
Duluth, GA 30097
678.417.7626 phone
678.417.7325 fax